Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / chronic weight management (commercial, when benefit is elected) | Covered with PA |
| Obesity / weight management (Humana Medicare Advantage) | Not covered |
Plan type: Commercial employer-sponsored plans (fully insured and self-funded). Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
This varies by plan. About 64 percent of workers covered through Humana employer-sponsored plans are in self-funded plans, where the employer independently decides which drug benefits to include. Roughly 41 percent of employers exclude anti-obesity medications from their self-funded plan designs. The Humana standard commercial formulary would cover Wegovy and Zepbound with prior authorization, but your employer's plan document is what governs. Check your summary of benefits or call the number on your card (1-800-448-6262).
Coverage by indication
| BMI threshold | BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) |
| Step therapy | Some plan designs require step therapy with Wegovy before Zepbound approval. The step requirement can be waived with documented contraindication or prior treatment failure. |
What the prior authorization needs:
- Your employer group must have elected the weight-management drug benefit
- Prior authorization is required
- BMI within the accepted threshold
- Documentation of a structured weight-management program for at least 6 months within the past 24 months
- Prescriber attestation that lifestyle modifications alone proved inadequate
- Ongoing reduced-calorie diet and increased physical activity while on therapy
Source: Humana 2026 Prescription Drug Guide (PDF, updated 2026). Official payer formulary guide (public URL confirmed, binary; tier placement and PA requirement confirmed; specific BMI PA criteria cross-checked against KFF commercial coverage analysis and published telehealth-platform PA experience). Verified June 18, 2026. This row is marked lower confidence: the policy document was confirmed at its public URL but served as an unreadable file, so the policy number and framework were cross-checked against secondary sources.
Humana Medicare Advantage (all plans) follows the Medicare Part D statutory exclusion under the Medicare Modernization Act of 2003, which prohibits Part D plans from covering drugs used solely for weight loss. This applies regardless of plan tier or formulary. Wegovy for established cardiovascular disease and Zepbound for moderate-to-severe sleep apnea may be covered under non-obesity indications when on the specific plan's drug list.
Source: Humana, Does Medicare cover weight-loss drugs? (Official Humana member resource page). Official payer member resource page (HTML, fetched directly). Verified June 18, 2026.
Coming in 2026: The Medicare GLP-1 Bridge (BALANCE Model) launches July 1, 2026, offering a $50 per month pathway for eligible Humana Medicare Advantage Part D members for Wegovy and Zepbound for weight management. This is a voluntary CMS demonstration and does not affect commercial Humana plans.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
- If your plan does not cover the indication you need, compare cash-pay options in the cost guide and the cheapest legitimate programs.
Frequently asked questions
Does Humana cover Wegovy and Zepbound?
It depends on your plan. Humana's commercial formulary includes Wegovy and Zepbound at Tier 3, but anti-obesity drug coverage is employer-elected. Many employers with Humana-administered plans have not elected the weight-management drug benefit. Humana Medicare Advantage does not cover either drug for weight loss, under the federal Medicare Part D obesity exclusion. This reflects the published policy verified June 2026.
What does Humana require to approve Wegovy and Zepbound?
For obesity / chronic weight management (commercial, when benefit is elected): The BMI requirement is BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease). Some plan designs require step therapy with Wegovy before Zepbound approval. The step requirement can be waived with documented contraindication or prior treatment failure.
Why might Humana deny Wegovy and Zepbound even if I meet the criteria?
About 64 percent of workers covered through Humana employer-sponsored plans are in self-funded plans, where the employer independently decides which drug benefits to include. Roughly 41 percent of employers exclude anti-obesity medications from their self-funded plan designs. The Humana standard commercial formulary would cover Wegovy and Zepbound with prior authorization, but your employer's plan document is what governs. Check your summary of benefits or call the number on your card (1-800-448-6262).
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources; those rows are marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit. Those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
